MyFinsight
Home
Blog
About
Back
Income Statement
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)
source: myfinsight.com
Revenue
$243,600K
(55.36%↑ Y/Y)
Income from operations
$27,194K
(34.89%↑ Y/Y)
Other income, net
$3,951K
(45.42%↑ Y/Y)
Total operating
expenses
$216,406K
(58.38%↑ Y/Y)
Income before income
taxes
$31,145K
(36.14%↑ Y/Y)
Collaboration expenses
$88,069K
(68.01%↑ Y/Y)
Selling, general and
administrative
$63,866K
(36.28%↑ Y/Y)
Research and development
$40,899K
(118.09%↑ Y/Y)
Cost of goods sold
$23,572K
(26.71%↑ Y/Y)
Net income
$25,432K
(42.62%↑ Y/Y)
Provision for income taxes
$5,713K
(13.24%↑ Y/Y)
Total comprehensive
income
$24,717K
(37.75%↑ Y/Y)
Total other
comprehensive income (loss)
-$715K
(-738.39%↓ Y/Y)
Unrealized gain (loss) on
short-term investments and...
-$715K
(-738.39%↓ Y/Y)
Back